ACHFF
Price
$0.74
Change
+$0.01 (+1.37%)
Updated
Nov 19 closing price
Capitalization
49.8M
Intraday BUY SELL Signals
AGTX
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Nov 19 closing price
Capitalization
1.72M
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHFF vs AGTX

Header iconACHFF vs AGTX Comparison
Open Charts ACHFF vs AGTXBanner chart's image
Arch Biopartners
Price$0.74
Change+$0.01 (+1.37%)
Volume$74.35K
Capitalization49.8M
Agentix
Price$0.04
Change-$0.00 (-0.00%)
Volume$5K
Capitalization1.72M
ACHFF vs AGTX Comparison Chart in %
ACHFF
Daily Signal:
Gain/Loss:
AGTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACHFF vs. AGTX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHFF is a Hold and AGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ACHFF: $0.74 vs. AGTX: $0.04)
Brand notoriety: ACHFF and AGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHFF: 172% vs. AGTX: 28%
Market capitalization -- ACHFF: $49.8M vs. AGTX: $1.72M
ACHFF [@Biotechnology] is valued at $49.8M. AGTX’s [@Biotechnology] market capitalization is $1.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHFF’s FA Score shows that 0 FA rating(s) are green whileAGTX’s FA Score has 1 green FA rating(s).

  • ACHFF’s FA Score: 0 green, 5 red.
  • AGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, AGTX is a better buy in the long-term than ACHFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHFF’s TA Score shows that 4 TA indicator(s) are bullish while AGTX’s TA Score has 4 bullish TA indicator(s).

  • ACHFF’s TA Score: 4 bullish, 3 bearish.
  • AGTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACHFF is a better buy in the short-term than AGTX.

Price Growth

ACHFF (@Biotechnology) experienced а -2.55% price change this week, while AGTX (@Biotechnology) price change was -4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHFF($49.8M) has a higher market cap than AGTX($1.72M). ACHFF YTD gains are higher at: -45.141 vs. AGTX (-75.771). AGTX has higher annual earnings (EBITDA): -545.9K vs. ACHFF (-2.07M). ACHFF has more cash in the bank: 167K vs. AGTX (4.41K). AGTX has less debt than ACHFF: AGTX (343K) vs ACHFF (2.44M). ACHFF (0) and AGTX (0) have equivalent revenues.
ACHFFAGTXACHFF / AGTX
Capitalization49.8M1.72M2,890%
EBITDA-2.07M-545.9K380%
Gain YTD-45.141-75.77160%
P/E RatioN/AN/A-
Revenue00-
Total Cash167K4.41K3,785%
Total Debt2.44M343K711%
FUNDAMENTALS RATINGS
ACHFF vs AGTX: Fundamental Ratings
ACHFF
AGTX
OUTLOOK RATING
1..100
251
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6547
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
4050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGTX's Valuation (4) in the null industry is significantly better than the same rating for ACHFF (95). This means that AGTX’s stock grew significantly faster than ACHFF’s over the last 12 months.

AGTX's Profit vs Risk Rating (100) in the null industry is in the same range as ACHFF (100). This means that AGTX’s stock grew similarly to ACHFF’s over the last 12 months.

AGTX's SMR Rating (100) in the null industry is in the same range as ACHFF (100). This means that AGTX’s stock grew similarly to ACHFF’s over the last 12 months.

AGTX's Price Growth Rating (47) in the null industry is in the same range as ACHFF (65). This means that AGTX’s stock grew similarly to ACHFF’s over the last 12 months.

ACHFF's P/E Growth Rating (97) in the null industry is in the same range as AGTX (100). This means that ACHFF’s stock grew similarly to AGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHFFAGTX
RSI
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
50%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 27 days ago
76%
Declines
ODDS (%)
Bearish Trend 23 days ago
78%
Bearish Trend 22 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
72%
Aroon
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ACHFF
Daily Signal:
Gain/Loss:
AGTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLPFY33.550.90
+2.76%
Teleperformance
CBAF32.000.70
+2.24%
Citba Financial Corp.
ORLCF0.03N/A
+0.70%
ORACLE COMMODITY HLDG CORP
CCGFF10.12N/A
N/A
Credit Corp Group Ltd.
CLNXF30.03-0.13
-0.44%
Cellnex Telecom SA

ACHFF and

Correlation & Price change

A.I.dvisor tells us that ACHFF and LABFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHFF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHFF
1D Price
Change %
ACHFF100%
+1.87%
LABFF - ACHFF
21%
Poorly correlated
N/A
ARGNF - ACHFF
11%
Poorly correlated
N/A
AGTX - ACHFF
4%
Poorly correlated
N/A
ADCT - ACHFF
4%
Poorly correlated
+0.50%
INBX - ACHFF
3%
Poorly correlated
+5.86%
More

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and RLAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and RLAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
N/A
RLAY - AGTX
32%
Poorly correlated
-2.30%
RVMD - AGTX
28%
Poorly correlated
-0.04%
SKYE - AGTX
23%
Poorly correlated
N/A
ALGS - AGTX
23%
Poorly correlated
+4.04%
BCYC - AGTX
22%
Poorly correlated
-3.32%
More